[PubMed] [Google Scholar] 192.Drmic D., Samara M., Vidovic T., Malekinusic D., Antunovic M., Vrdoljak B., Ruzman J., Milkovic Perisa M., Horvat Pavlov K., Jeyakumar J., et al
Serious but rare risks include pancreatitis, gallbladder issues, allergic reactions, and kidney problems
Additional areas of active investigation include the peptide's potential effects on bone healing, where studies have reported accelerated fracture consolidation in animal models
While randomized clinical trials have shown the efficacy of those medications, Dr
Learn more about the safety of ingredients in Centrum, including binders, fillers, and coloring agents
Journal of Clinical Endocrinology & Metabolism 2006 Reported that subcutaneous CJC-1295 produced sustained, dose-dependent increases in growth hormone and IGF-I in healthy adults